GRCE
Price
$3.09
Change
+$0.01 (+0.32%)
Updated
Sep 26 closing price
Capitalization
42.73M
TERN
Price
$7.64
Change
+$0.20 (+2.69%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
651.08M
53 days until earnings call
Interact to see
Advertisement

GRCE vs TERN

Header iconGRCE vs TERN Comparison
Open Charts GRCE vs TERNBanner chart's image
Grace Therapeutics
Price$3.09
Change+$0.01 (+0.32%)
Volume$29.11K
Capitalization42.73M
Terns Pharmaceuticals
Price$7.64
Change+$0.20 (+2.69%)
Volume$20.7K
Capitalization651.08M
GRCE vs TERN Comparison Chart in %
Loading...
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GRCE vs. TERN commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRCE is a Buy and TERN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (GRCE: $3.10 vs. TERN: $7.64)
Brand notoriety: GRCE and TERN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRCE: 21% vs. TERN: 55%
Market capitalization -- GRCE: $42.59M vs. TERN: $651.08M
GRCE [@Biotechnology] is valued at $42.59M. TERN’s [@Biotechnology] market capitalization is $651.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRCE’s FA Score shows that 0 FA rating(s) are green whileTERN’s FA Score has 0 green FA rating(s).

  • GRCE’s FA Score: 0 green, 5 red.
  • TERN’s FA Score: 0 green, 5 red.
According to our system of comparison, GRCE is a better buy in the long-term than TERN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRCE’s TA Score shows that 4 TA indicator(s) are bullish while TERN’s TA Score has 3 bullish TA indicator(s).

  • GRCE’s TA Score: 4 bullish, 5 bearish.
  • TERN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, GRCE is a better buy in the short-term than TERN.

Price Growth

GRCE (@Biotechnology) experienced а -0.16% price change this week, while TERN (@Biotechnology) price change was +1.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.14%. For the same industry, the average monthly price growth was +9.25%, and the average quarterly price growth was +54.64%.

Reported Earning Dates

TERN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+4.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TERN($651M) has a higher market cap than GRCE($42.7M). TERN YTD gains are higher at: 37.906 vs. GRCE (-17.380). GRCE has higher annual earnings (EBITDA): -14.8M vs. TERN (-105M). TERN has more cash in the bank: 315M vs. GRCE (20M). GRCE (0) and TERN (0) have equivalent revenues.
GRCETERNGRCE / TERN
Capitalization42.7M651M7%
EBITDA-14.8M-105M14%
Gain YTD-17.38037.906-46%
P/E RatioN/AN/A-
Revenue00-
Total Cash20M315M6%
Total DebtN/A1.13M-
FUNDAMENTALS RATINGS
GRCE: Fundamental Ratings
GRCE
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
PROFIT vs RISK RATING
1..100
49
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
43

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GRCETERN
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
GRCE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TERN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VASVX29.19N/A
N/A
Vanguard Selected Value Inv
BRXAX16.79N/A
N/A
MFS Blended Research Intl Eq A
JOPPX53.06N/A
N/A
Johnson Opportunity
EEIFX10.05N/A
N/A
Monteagle Enhanced Equity Income Instl
SSBIX14.12N/A
N/A
State Street Balanced Index K

GRCE and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRCE has been loosely correlated with SLNO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if GRCE jumps, then SLNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRCE
1D Price
Change %
GRCE100%
+0.32%
SLNO - GRCE
38%
Loosely correlated
+3.57%
CYTK - GRCE
37%
Loosely correlated
+5.37%
ASMB - GRCE
29%
Poorly correlated
-3.37%
ARGX - GRCE
28%
Poorly correlated
+0.07%
TERN - GRCE
27%
Poorly correlated
+2.69%
More

TERN and

Correlation & Price change

A.I.dvisor indicates that over the last year, TERN has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if TERN jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TERN
1D Price
Change %
TERN100%
+2.69%
SYRE - TERN
54%
Loosely correlated
+4.04%
BEAM - TERN
51%
Loosely correlated
-0.48%
OCUL - TERN
49%
Loosely correlated
+2.33%
IDYA - TERN
48%
Loosely correlated
+4.52%
XNCR - TERN
48%
Loosely correlated
+12.00%
More